Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Orchard Therapeutics
Orchard Therapeutics
(ORTX)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Atidarsagene autotemcel
metachromatic leukodystrophy
,
lysosomal storage diseases
Simoladagene autotemcel
severe combined immunodeficiency
,
immunologic deficiency syndromes
Arm1
healthy volunteers/patients
,
coronary artery disease
,
non-alcoholic fatty liver disease
,
fatty liver
,
alcoholic fatty liver
,
esophageal neoplasms
,
obesity
,
overweight
,
neoplasms
,
squamous cell carcinoma of head and neck
,
chronic urticaria
,
urticaria
,
type 1 diabetes mellitus
,
colorectal neoplasms
,
gastrointestinal endoscopy
,
renal cell carcinoma
,
body weight
,
weight loss
,
cholangiocarcinoma
,
biliary tract neoplasms
,
endometrial neoplasms
,
carcinosarcoma
,
mullerian mixed tumor
,
asthma
,
hypertension
,
kidney diseases
,
non-small-cell lung carcinoma
,
lung neoplasms
,
breast neoplasms
,
covid-19
,
carcinoma
,
triple negative breast neoplasms
,
prostatic neoplasms
,
ovarian neoplasms
,
squamous cell carcinoma
,
ovarian epithelial carcinoma
,
stomach neoplasms
,
urinary bladder neoplasms
,
small cell lung carcinoma
,
esophageal squamous cell carcinoma
,
oropharyngeal neoplasms
,
hepatocellular carcinoma
,
liver neoplasms
,
hypertriglyceridemia
,
esophagitis
,
infections
,
respiratory insufficiency
,
communicable diseases
,
hypersensitivity
,
adenocarcinoma
,
type 2 diabetes mellitus
,
diabetes mellitus
,
chronic obstructive pulmonary disease
,
lung diseases
,
obstructive lung diseases
,
renal insufficiency
,
kidney function tests
,
thromboembolism
,
atherosclerosis
,
systemic lupus erythematosus
,
post-traumatic stress disorders
,
combat disorders
,
traumatic stress disorders
Arm2
healthy volunteers/patients
,
coronary artery disease
,
esophageal neoplasms
,
obesity
,
overweight
,
squamous cell carcinoma of head and neck
,
chronic urticaria
,
urticaria
,
type 1 diabetes mellitus
,
cholangiocarcinoma
,
biliary tract neoplasms
,
neoplasms
,
renal cell carcinoma
,
endometrial neoplasms
,
carcinosarcoma
,
mullerian mixed tumor
,
gastrointestinal endoscopy
,
hypertension
,
kidney diseases
,
non-small-cell lung carcinoma
,
lung neoplasms
,
breast neoplasms
,
covid-19
,
carcinoma
,
triple negative breast neoplasms
,
prostatic neoplasms
,
ovarian neoplasms
,
squamous cell carcinoma
,
ovarian epithelial carcinoma
,
stomach neoplasms
,
urinary bladder neoplasms
,
small cell lung carcinoma
,
asthma
,
esophageal squamous cell carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
,
hypertriglyceridemia
,
esophagitis
,
infections
,
respiratory insufficiency
,
communicable diseases
,
hypersensitivity
,
exercise-induced asthma
,
adenocarcinoma
,
type 2 diabetes mellitus
,
diabetes mellitus
,
chronic obstructive pulmonary disease
,
lung diseases
,
obstructive lung diseases
,
thromboembolism
,
atherosclerosis
,
systemic lupus erythematosus
,
renal insufficiency
,
kidney function tests
,
post-traumatic stress disorders
,
combat disorders
,
traumatic stress disorders
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use